Paperpal Prime Logo

Regenerative Therapy : Impact Factor & More

eISSN: 2352-3204pISSN: 2352-3204
JournalOpen Access

Aims and Scope of Regenerative Therapy

Regenerative Therapy is the official peer-reviewed online journal of the Japanese Society for Regenerative Medicine.

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q4Biomaterials
SNIP
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Regenerative Therapy

Regenerative Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Irregular
Article Processing ChargesUSD 1100
Publication Time25
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorJapanese Society for Regenerative Medicine
FrequencyIrregular
Publication Start Year2015
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 25
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Regenerative Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Regenerative Therapy

Punicalagin alleviates senile osteoporosis by inhibiting the senescence of bone mesenchymal stem cells via NRF2/HO-1 pathway.
  • 1 Dec 2026
  • Regenerative therapy
Long-term expandable auricular chondrocytes reveal a conserved nine-gene decline module underlying senescence-independent dedifferentiation.
  • 1 Dec 2026
  • Regenerative therapy
Host-state biomarkers and clinical factors for stratification and optimization of cell therapy trials in chronic limb-threatening ischemia: A review.
  • 1 Dec 2026
  • Regenerative therapy
Design and initial evaluation of a certified committee model for review of in vivo gene therapy and related technologies, together with ex vivo gene therapy, under the act on the safety of regenerative medicine.
  • 1 Dec 2026
  • Regenerative therapy
CXCL12-abundant reticular cell lineage is the key source of endosteal osteoblasts and adipocytes in adult bone marrow.
  • 1 Dec 2026
  • Regenerative therapy
Bypassing pluripotency: The promise of direct differentiation from reaggregated micro-fat into multilineage organoids.
  • 1 Dec 2026
  • Regenerative therapy
Punicalagin alleviates senile osteoporosis by inhibiting the senescence of bone mesenchymal stem cells via NRF2/HO-1 pathway.
  • 1 Dec 2026
  • Regenerative therapy
Long-term expandable auricular chondrocytes reveal a conserved nine-gene decline module underlying senescence-independent dedifferentiation.
  • 1 Dec 2026
  • Regenerative therapy
Host-state biomarkers and clinical factors for stratification and optimization of cell therapy trials in chronic limb-threatening ischemia: A review.
  • 1 Dec 2026
  • Regenerative therapy
Design and initial evaluation of a certified committee model for review of in vivo gene therapy and related technologies, together with ex vivo gene therapy, under the act on the safety of regenerative medicine.
  • 1 Dec 2026
  • Regenerative therapy
CXCL12-abundant reticular cell lineage is the key source of endosteal osteoblasts and adipocytes in adult bone marrow.
  • 1 Dec 2026
  • Regenerative therapy
Bypassing pluripotency: The promise of direct differentiation from reaggregated micro-fat into multilineage organoids.
  • 1 Dec 2026
  • Regenerative therapy

FAQs on Regenerative Therapy